HEATHER LAQUERRE: Open Payments
NPI 1508199274 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$271 in 7 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $271
Food & beverage: $271
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $139 |
| CSL Behring | 1 | $34 |
| Regeneron Healthcare Solutions, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $26 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
| PFIZER INC. | 1 | $20 |
Products named: FASENRA, Hizentra, DUPIXENT, CUVITRU, NEFFY, PAXLOVID, TEZSPIRE.
Industry payments across OK — which companies pay providers there.
